MARKET

BIO-B

BIO-B

BIO RAD LABORATO
NYSE

Real-time Quotes | Nasdaq Last Sale

600.70
0.00
0.00%
Opening 09:30 03/05 EST
OPEN
--
PREV CLOSE
600.70
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
668.56
52 WEEK LOW
324.07
MARKET CAP
17.93B
P/E (TTM)
4.757
1D
5D
1M
3M
1Y
5Y
Fitch Rates Agilent's Senior Unsecured Notes 'BBB+'
reuters.com · 2d ago
Fitch Upgrades Thermo Fisher's Long-Term IDR to 'BBB+'; Outlook Stable
reuters.com · 3d ago
BRIEF-Bio-Rad Reports Fourth-Quarter And Full-Year 2020 Financial Results
reuters.com · 02/11 22:31
From Netflix's 'Queen's Gambit' to HBO's 'Undoing,' here's how the miniseries is leading TVs revolution
Miniseries are back in vogue, and an expert explains why the format -- once left for dead -- is making a comeback.
Yahoo Finance · 02/06 15:38
Super Bowl LV commercials: Cheetos creates buzz, Chipotle drops its first-ever commercial
Cheetos, M&M's, Anheuser-Busch and Chipotle drop primetime ads ahead of Super Bowl Sunday.
Yahoo Finance · 02/06 15:37
From pizza to wings, here's what Americans will be snacking on during Super Bowl 2021
Here's what Americans will be snacking on during Super Bowl LV.
Yahoo Finance · 02/06 14:53
A typical day for Ark Invest's star stock picker Cathie Wood
Ark Invest's Cathie Wood on her typical day.
Yahoo Finance · 02/06 14:24
Why rich people leaving California isn't what you think
Taxes, onerous regulations, the high cost of salaries, rent — all this has given Bay area denizens permission to pack up their wine cellars and their $10,000 hand painted Italian bicycles and go. But is this urge to leave the Golden State really new, or is...
Yahoo Finance · 02/06 13:03
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIO-B. Analyze the recent business situations of BIO RAD LABORATO through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-3.03%
Healthcare Equipment & Supplies
-2.88%
Key Executives
Chairman/President/Chief Executive Officer/Director
Norman Schwartz
Chief Financial Officer/Executive Vice President
Ilan Daskal
Chief Operating Officer/Executive Vice President
Andrew Last
Executive Vice President/General Counsel/Secretary
Timothy Ernst
Executive Vice President
Michael Crowley
Executive Vice President
Giovanni Magni
Executive Vice President
Annette Tumolo
Executive Vice President
Dara Wright
Senior Vice President/Chief Accounting Officer
Ajit Ramalingam
Vice President/Treasurer
Ronald Hutton
Lead Director/Independent Director
Gregory Hinckley
Director
Alice Schwartz
Independent Director
Jeffrey Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold Pinkston
No Data
About BIO-B
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO B real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO B stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIO-B stock methods without spending real money on the virtual paper trading platform.